Smith Group Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Smith Group Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,450	Closed	-$91K	–	341
2020 Q2	$91K	Sell	1,450 -20	-1%	-$1.1K	0.01%	197
2020 Q1	$62K	Hold	1,470	–	–	﹤0.01%	236
2019 Q4	$67K	Hold	1,470	–	–	﹤0.01%	263
2019 Q3	$67K	Buy	1,470 +300	+26%	+$16.9K	﹤0.01%	261
2019 Q2	$69K	Hold	1,170	–	–	﹤0.01%	258
2019 Q1	$52K	Sell	1,170 -4,200	-78%	-$193K	﹤0.01%	298
2018 Q4	$209K	Sell	5,370 -200	-4%	-$7.85K	0.01%	241
2018 Q3	$256K	Sell	5,570 -110	-2%	-$4.46K	0.01%	237
2018 Q2	$248K	Buy	+5,680	New	+$244K	0.01%	236
2013 Q3	–	Sell	-7,667	Closed	-$590K	–	450
2013 Q2	$590K	Buy	+7,667	New	+$626K	0.03%	204

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Smith Group Asset Management's ARNA Position: Q3 2020 in Review

Smith Group Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 1,450 shares — an estimated $91K sold.

Smith Group Asset Management first reported a position in ARNA in Q2 2013 and held it in 10 quarters. The position peaked at $590K in Q2 2013. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

Smith Group Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
Smith Group Asset Management sold 1,450 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $91K.
Smith Group Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
Smith Group Asset Management's Arena Pharmaceuticals Inc position peaked at $590K in Q2 2013.
253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.